PET imaging of atherosclerotic plaques using the stabilin-2-targeted tracer 18F-S2P in preclinical models
European Journal of Nuclear Medicine and Molecular Imaging · 2026
DOI: 10.1007/s00259-026-08033-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, 2026. Verfasst von Dilibire Adili und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China. Hauptthemen laut MEDLINE: Plaque, Atherosclerotic, Positron Emission Tomography Computed Tomography, Positron-Emission Tomography, Fluorine Radioisotopes. Die Arbeit nennt 27 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Zhejiang Province Vanguard Plan Project.
Abstract (Originalsprache)
PURPOSE: Elevated Stabilin-2 (STAB2) expression in macrophages within atherosclerotic plaques offers a promising molecular target for imaging vascular inflammation. The S2P peptide specifically binds STAB2. This study aims to evaluate the feasibility of using the STAB2-targeted 18F-labeled tracer (18F-S2P) for positron emission tomography (PET) imaging to identify atherosclerotic plaques. METHODS: Stab2 expression was validated via single-cell RNA sequencing of Ldlr-/- mouse samples. Biodistribution and micro-PET/CT imaging were performed in high-fat diet-fed Ldlr-/- mice (3-12 weeks) and chow-fed controls, with comparisons to 18F-FDG and 18F-Pentixafor. Plaque burden and macrophage infiltration were evaluated using Oil Red O, H&E, and immunofluorescence staining. Immunohistochemical staining was used to detect STAB2 expression in human atherosclerotic specimens. RESULTS: ScRNA-seq analysis identified Stab2 as a macrophage-specific marker in atherosclerosis plaque. In vivo micro-PET/CT quantification revealed disease duration-dependent uptake (1.41 ± 0.31 ID%/g at 3 weeks vs. 2.17 ± 0.19 ID%/g at 12 weeks, P < 0.0001), which positively correlated with histological plaque burden. 18F-S2P PET imaging demonstrated 5.4-fold higher plaque uptake in Ldlr-/- mice compared to wild-type controls (P < 0.0001), significantly outperforming 18F-FDG (1.52-fold) and 18F-Pentixafor (1.89-fold) in atherosclerotic lesions. Furthermore, STAB2 was also detectable in human atherosclerotic plaques. CONCLUSION: This study introduces a novel STAB2-targeted PET probe (18F-S2P) for non-invasive imaging of atherosclerotic plaques in preclinical models, enabling the detection of atherosclerotic inflammation. The endogenous expression of STAB2 in human atherosclerotic lesions further strengthens the translational potential of this imaging strategy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
- Department of Sports Medicine & Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
- Department of Pathology, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
- Department of Pathology, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
- Clinical Research Center, Department of Cardiology, The Third Xiangya Hospital, Central South University, Changsha, China.
- Department of Ultrasound Medicine, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Zhejiang Province Vanguard Plan Project
- Science and Technology Department of the State Administration of Traditional Chinese Medicine and the Zhejiang Provincial Administration of Traditional Chinese…
- National High Performance Medical Device Innovation Center Innovation Fund
Zitieren
APA
Adili, D., Zhang, D., Wang, G., Jin, H., Sun, K., Zhao, S., Wu, J., Su, C., Shi, H., Li, Z., & Su, X. (2026). PET imaging of atherosclerotic plaques using the stabilin-2-targeted tracer 18F-S2P in preclinical models. European Journal of Nuclear Medicine and Molecular Imaging. https://doi.org/10.1007/s00259-026-08033-8
Vancouver
Adili D, Zhang D, Wang G, Jin H, Sun K, Zhao S, et al. PET imaging of atherosclerotic plaques using the stabilin-2-targeted tracer 18F-S2P in preclinical models. European Journal of Nuclear Medicine and Molecular Imaging. 2026. doi:10.1007/s00259-026-08033-8
BibTeX
@article{Adili2026,
author = {Adili, Dilibire and Zhang, Dongsheng and Wang, Guangfa and Jin, Haocheng and Sun, Ke and Zhao, Shanshan and Wu, Junru and Su, Chen and Shi, Hongcheng and Li, Zan and Su, Xinhui},
title = {PET imaging of atherosclerotic plaques using the stabilin-2-targeted tracer 18F-S2P in preclinical models},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
doi = {10.1007/s00259-026-08033-8}
}
EUVIMED